NCT00957944View on ClinicalTrials.gov

Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Healthy Volunteers
Interventions
DRUG

rotigotine transdermal patch (Neupro®)

Rotigotine 4.5 mg/10 cm\^2 patch applied for 24 hours

Trial Locations (1)

Unknown

Neuss

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY